FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorder

The FDA approved Mimrylo (rusfertide), the first drug that mimics hepcidin to treat adults with polycythemia vera, significantly reducing the need for frequent phlebotomies in patients whose disease was not controlled by existing therapies.

This Wire brief sits within Fusion42's coverage of Biotech.